Thought Leadership for Life Science Leaders

Blog

Speak to Our Thought Leaders Today

New Era of FDA Enforcement: Increased Outsourcing and Offshoring

On Thursday, March 11, 2010, Jack Garvey, Principal, Compliance Architects LLC, will be presenting an audio conference in conjunction with FXTranslations  and FXConferences entitled “Outsourcing and Offshoring in a New Era of FDA Enforcement.”  This audio conference will be of great help to companies that use contract product or service providers, either within the US or outside of the US.   

From the Conference Registration Page

The increasing use of outsourcing and offshoring by FDA-regulated companies for strategic and cost purposes has greatly improved business outcomes and efficiencies. Unfortunately, despite the clear benefits, there are many significant challenges to structuring and managing these relationships to minimize the risk of FDA enforcement, particularly in the new, more aggressive FDA enforcement climate.

In this audio conference, our speaker provides some business context regarding the use of offshoring and outsourcing, and discusses issues and considerations in structuring relationships, as well as considerations in planning for FDA review and inspection of oversight programs.

This audio conference covers:

  • How to select a contractor
  • Managing contract relationships
  • Elements of the quality system interface
  • Current FDA requirements & expectations
  • How the FDA might change its approach
  • What your company should be doing over the next 18 months

To register for this FDA enforcement event, please visit the FXConferences registration page.

fda enforcement

Contact Us

To learn more about the new era of FDA enforcement, fill out the form below to contact us.

Advancing Clinical Investigator Site Audits: A Quality-Focused, Risk-Based Approach

Clinical research is undergoing a profound transformation, driven by technological innovation, globalization, evolving...

Learning from Recent FDA Warning Letters: A Call for Proactive Compliance

Every FDA Warning Letter offers more than a glimpse into individual noncompliance; it...

Informed consent is one of the most vital elements of ethical clinical research....